Testing and assurance technology company Spirent Communications said it expected to deliver a rise in adjusted full-year earnings, assisted by revenue growth of 5.5%.
AstraZeneca and MSD said their application for a drug used to treat advanced ovarian cancer had been accepted and granted priority review in the US....